D.C. Circuit Rejects Mylan's Bid To Make Generic Duragesic
A U.S. appeals court in Washington, D.C. has rejected Mylan Laboratories' bid to market a generic version of Johnson & Johnson's Duragesic pain-relief skin patch....To view the full article, register now.
Already a subscriber? Click here to view full article